Health
A nanoscaffolding approach for rapid design of highly immunogenic SARS-CoV-2 vaccines – News-Medical.net
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the adv…
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the advance of such platforms in the pursuit for the effective vaccine. Their results are currently available on bioRxiv* preprint server.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative agent of the ongoing COVID-19 pa…
-
General15 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals
-
General11 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
Noosa News11 hours agoDingo hunts shark in shallow waters off K’gari, Queensland
-
Noosa News5 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute
